These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glucagon: its mechanism of action on the coronary circulation in the conscious dog. Terry B; White FC; Bloor CM Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531 [No Abstract] [Full Text] [Related]
4. Effects of glucagon on the splanchnic and the systemic circulation. Madden JJ; Ludewig RM; Wangensteen SL Am J Surg; 1971 Jul; 122(1):85-90. PubMed ID: 5091860 [No Abstract] [Full Text] [Related]
5. The correlation between haemodynamic changes and arterial blood halothane concentrations during halothane-nitrous oxide anaesthesia in the dog. Gil-Rodriguez JA; Hill DW; Lundberg S Br J Anaesth; 1971 Feb; 43(2):202-3. PubMed ID: 5550854 [No Abstract] [Full Text] [Related]
6. [Effect of indigocarmine on hemodynamics and on coronary perfusion in dogs]. Patschke D; Gethmann JW; Tarnow J; Weymar A Anaesthesist; 1973 Jul; 22(7):305-7. PubMed ID: 4730135 [No Abstract] [Full Text] [Related]
7. A role for glucagon in cardiac therapy. Parmley WW; Sonnenblick EH Am J Med Sci; 1969 Oct; 258(4):224-9. PubMed ID: 4309903 [No Abstract] [Full Text] [Related]
8. [Experimental and clinical studies on the cardiovascular effects of glucagon]. Ijima H; Hori M; Tomino T; Kune H; Okai O Nihon Kyobu Geka Gakkai Zasshi; 1974 Feb; 22(2):110-20. PubMed ID: 4858969 [No Abstract] [Full Text] [Related]
9. [Experimental studies on the influence of dopamine, glucagon, effortil, noradrenaline and dextran on haemodynamics during deep halothane anaesthesia]. Tarnow J; Brückner JB; Eberlein HJ; Patschke D; Reinecke A; Schmicke P Anaesthesist; 1973 Jan; 22(1):8-15. PubMed ID: 4692615 [No Abstract] [Full Text] [Related]
10. Glucagon infusion following phosphodiesterase inhibition: an experimental study of the hemodynamic effects. Mitts TF; Jolley WB; Smith LL Arch Surg; 1973 Jul; 107(1):12-5. PubMed ID: 4351677 [No Abstract] [Full Text] [Related]
11. Cardiovascular effects of glucagon in the intact anesthetized and hepatectomized dog. Pappas G; Guillen J; Aldrete JA Surgery; 1970 Aug; 68(2):363-8. PubMed ID: 5450717 [No Abstract] [Full Text] [Related]
12. Effect of glucagon on pulmonary vascular resistance. Kirsh MM; Kahn DR; Lucchesi B; Gago O; Dufek JH; Lee RW; Stutz D; Sloan H Surgery; 1971 Sep; 70(3):439-42. PubMed ID: 5568529 [No Abstract] [Full Text] [Related]
13. Alteration of cardiac contractility and hemodynamics by phosphodiesterase inhibition. Hohl MK; Jolley WB; Smith LL Surg Forum; 1974; 25(0):158-60. PubMed ID: 4373844 [No Abstract] [Full Text] [Related]
14. The cardiovascular effects of methylmethacrylate. Ellis RH; Mulvein J J Bone Joint Surg Br; 1974 Feb; 56(1):59-61. PubMed ID: 4818855 [No Abstract] [Full Text] [Related]
16. [Effect of intermittent glucagon doses on blood circulation in the early postoperative phase after heart surgery]. Hempelmann G; Ardalan H; Piepenbrock S; Helms U; Westermann C Z Kardiol; 1974 Jun; 63(6):511-20. PubMed ID: 4409370 [No Abstract] [Full Text] [Related]
17. Increase in hepatic blood flow and d-propranolol clearance by glucagon in the monkey. Branch RA; Shand DG; Nies AS J Pharmacol Exp Ther; 1973 Dec; 187(3):581-7. PubMed ID: 4203721 [No Abstract] [Full Text] [Related]
18. [Fluroxene as an anesthetic agent in patients with cardiac disease]. Wiberg-Jorgensen F; Henriksen H; Skovsted P Ugeskr Laeger; 1972 Jan; 134(3):94-9. PubMed ID: 4400825 [No Abstract] [Full Text] [Related]